The FTC complaint, filed on July 29, 2026, alleges that Hims & Hers engaged in deceptive privacy practices by funneling medical information to platforms including Snap and Meta. This revelation caused immediate market volatility, leaving many investors with significant financial losses and raising questions regarding the company's internal disclosure protocols.
Kessler Topaz Launches Investigation into Hims & Hers Privacy Practices
A 14% plunge in Hims & Hers Health stock has triggered a formal investigation by the law firm Kessler Topaz Meltzer & Check. Attorneys are scrutinizing potential federal securities law violations following a July lawsuit from the Federal Trade Commission that accused the company of sharing sensitive patient health data with third-party advertisers.
Kessler Topaz Meltzer & Check, a firm specializing in securities litigation, is now representing shareholders seeking to address these losses. Investors who acquired HIMS securities and suffered a decline in portfolio value are encouraged to contact attorney Jonathan Naji to discuss potential legal recourse. The firm notes that consultations remain free of charge and carry no obligation for those seeking to understand their rights under federal law.
Comments (0)
No comments yet. Be the first!